treatment of cushing’s syndrome...• patient is placed on metformin with normalization of blood...
TRANSCRIPT
![Page 1: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/1.jpg)
Treatment of Cushing’s Syndrome:
An Endocrine Society Clinical Practice Guideline
![Page 2: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/2.jpg)
Task Force MembersLynnette Nieman, MD (chair)Lawrence S. Kirschner, MD, PhDBeverly M. K. Biller, MD, FACPJames Findling, MDJohn Newell-Price, MD, PhD, FRCPMartin Savage, MDAntoine Tabarin, MD
![Page 3: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/3.jpg)
Contents
I. Clinical Case QuestionsII. Presentation of Task Force
Guidelines
III. Review of Case
![Page 4: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/4.jpg)
I. Clinical Case Questions
![Page 5: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/5.jpg)
BH is a 33-year-old woman who complains of a 44 lb (20 kg) weight gain over the past year. She is a former high school gymnast who maintained her weight, including after the birth of her two children (aged 4 and 7).
Clinical Case: BH
Other symptoms:• Irregular menses• Polyuria• Dry itchy skin• Insomnia• Increased irritability
Other medical history• Past medical and family history:
Unremarkable• Non-smoker, minimal alcohol
usage• Medications: multivitamin
Physical examination:• Blood pressure 155/90• Face round and reddened• Purplish abdominal striae with
generally thin skin
![Page 6: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/6.jpg)
Lab Investigations
Clinical Case: BH (con’t)
Test ResultFasting blood sugar[normal <106 mg/dl (<0.88 mmol/L)]
176 mg/dl (9.8 mmol/L)
Cortisol after 1mg Dexamethasone [normal <1.8 mcg/dl (49.7 nmol/L)]
7.6 mcg/dl (209.8 nmol/L)
24-hr Urine free cortisol (UFC)[normal <45 mcg (124 nmol/L)]
220 mcg/day (660 nmol/day)
8 AM ACTH[normal 9-50 pg/ml (1.98-11 pmol/L)]
78 pg/ml (17.2 pmol/L)
Pituitary MRI 9 mm right lateral hypodensity
![Page 7: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/7.jpg)
A. Transsphenoidal surgeryB. Steroidogenesis inhibitors (e.g. ketoconazole, metyrapone)C. Glucocorticoid blocker (mifepristone)D. Somatostatin analog (pasireotide)E. Bilateral adrenalectomy
Clinical Case: BHQuestion 1: Therapeutic Intervention
What first therapeutic intervention do you favor?
![Page 8: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/8.jpg)
A. Transsphenoidal surgeryB. Steroidogenesis inhibitors (e.g. ketoconazole, metyrapone)C. Glucocorticoid blocker (mifepristone)D. Somatostatin analog (pasireotide)E. Bilateral adrenalectomy
Clinical Case: BHQuestion 1: Therapeutic Intervention
What first therapeutic intervention do you favor?
![Page 9: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/9.jpg)
Clinical Case: BHPeri-operative Course
• The patient is referred to an experienced pituitary surgeon, who removed the tumor without complication.
o Pathology reveals a typical pituitary adenoma, which stains only for ACTH.
o Post-operatively, the cortisol drops to 1.0 mcg/dl (27.6 nmol/L), and the patient feels ill.
• She is given hydrocortisone and discharged on replacement doses. She has no symptoms of diabetes insipidus.
• Her blood sugar and blood pressure normalize.
![Page 10: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/10.jpg)
Clinical Case: BHPost-operative Course
• Over the next few months, she remains wello No anti-hypertensiveso No anti-diabetic medications
• A follow-up MRI at 6 months shows only post-op changes
• At 9 months, she is weaned off the hydrocortisone and feels well.
![Page 11: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/11.jpg)
Clinical Case: BHOne-year later…
• 20 months post-op, the patient calls the office concerned about recurrence of the Cushing’s syndrome
• She complains of “not feeling well” but is unable to be more specific
• She had lost 40 pounds (18 kg) over the preceding year, but has regained 5 pounds (2.5 kg) over the past few months
• Exam is unremarkable
![Page 12: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/12.jpg)
A. Repeat MRIB. 24-hr Urine free cortisol (UFC)C. Dexamethasone suppression testD. Late night salivary cortisol
Clinical Case: BHQuestion 2: Diagnostic Testing
Which initial diagnostic test do you favor to assess for disease recurrence?
![Page 13: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/13.jpg)
A. Repeat MRIB. 24-hr Urine free cortisol (UFC)C. Dexamethasone suppression testD. Late night salivary cortisol
Clinical Case: BHQuestion 2: Diagnostic Testing
Which initial diagnostic test do you favor to assess for disease recurrence?
![Page 14: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/14.jpg)
Clinical Case: BH20–26 months Post-operative
• Biochemical testing returns normal
• 6 months later, the patient has gained another 5 lbs(2.5 kg)
• Exam unremarkable, but screening bloodwork indicates a fasting glucose of 135 mg/dl (7.4 mmol/L)
![Page 15: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/15.jpg)
Clinical Case: BHLabs at 26 months Post-operation
• UFC: 40 mcg/day (110.4 nmol/day)o [normal <45 mcg/day (124 nmol/day)]
• 1-mg dex suppression test: 2.3 mcg/dl (63.5 nmol/L)o [normal <1.8 ug/dl (49.7 nmol/L)]
• Late night salivary cortisol: 180 ng/dL (4.97 nmol/L)o [normal <100 ng/dL (2.76 nmol/L)]
![Page 16: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/16.jpg)
A. Treat co-morbidities onlyB. Repeat pituitary surgeryC. Radiation therapyD. Medical therapyE. Bilateral adrenalectomy
Clinical Case: BHQuestion 3: Further Interventions
Which intervention would you select at this time?
![Page 17: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/17.jpg)
A. Treat co-morbidities onlyB. Repeat pituitary surgeryC. Radiation therapyD. Medical therapyE. Bilateral adrenalectomy
Clinical Case: BHQuestion 3: Further Interventions
Which intervention would you select at this time?
![Page 18: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/18.jpg)
Clinical Case: BH26–30 months Post-operative
• Patient is placed on metformin with normalization of blood glucose.
• 4 months later, she has gained an additional 10 lbs [5 kg]. She now requires 2 oral medications for her diabetes.
• Exam shows BP 150/90, and she has recurrent moon facies and skin changes.
• UFC 75 mcg/day (207 nmol/day) [normal <45 mcg/day (124.2 nmol/day)]
• Late night salivary 300 ng/dL (8.28 nmol/L) [normal <100 ng/dL (2.76 nmol/L)]
• MRI is stable, showing only post-op changes
![Page 19: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/19.jpg)
A. Treat co-morbidities onlyB. Repeat pituitary surgeryC. Radiation therapyD. Medical therapyE. Bilateral adrenalectomy
Clinical Case: BHQuestion 4: Further Interventions
Which intervention would you select at this time?
![Page 20: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/20.jpg)
A. Treat co-morbidities onlyB. Repeat pituitary surgeryC. Radiation therapyD. Medical therapyE. Bilateral adrenalectomy
Clinical Case: BHQuestion 4: Further Interventions
Which intervention would you select at this time?
![Page 21: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/21.jpg)
Clinical Case: BH30 months Post-operative
• The surgeon does not feel that further pituitary surgery would be valuable
• The patient is offered radiation therapy but declines.
• She is next offered medical therapy
![Page 22: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/22.jpg)
A. KetoconazoleB. MetyraponeC. MifepristoneD. PasireotideE. CabergolineF. Another option
Clinical Case: BHQuestion 5: Medical Therapy
Which medical therapy would you select at this time?
![Page 23: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/23.jpg)
A. KetoconazoleB. MetyraponeC. MifepristoneD. PasireotideE. CabergolineF. Another option
Clinical Case: BHQuestion 5: Medical Therapy
Which medical therapy would you select at this time?
![Page 24: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/24.jpg)
II. Presentation of Task Force Guidelines
![Page 25: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/25.jpg)
Conversely, in severe CS, treatment may be life-saving and should not be delayed
Cushing’s Syndrome: Who to treat?“Barn Door” Cushing’s
If the diagnosis of CS is not clear, do not treat
![Page 26: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/26.jpg)
• Operation by an experienced surgeon is the optimal initial treatment.
• Measurement of cortisol during treatment is a surrogate marker for normalization.
• Normalization of comorbidities is the goal.• Use late night salivary cortisol to detect recurrence• Individualize the choice of second line therapy• Know what we don’t know.
Cushing’s Syndrome: Major Points
![Page 27: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/27.jpg)
III.Review of Treatment Approaches and Special Situations
![Page 28: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/28.jpg)
Subtle RecurrenceTreatment Goals for Cushing’s Syndrome
The benefit of treating to normalize cortisol is not establishedin the setting of mild hypercortisolemia
Approach to Long-Term Follow-up Treat specific comorbidities
Future ResearchEvaluate the clinical effects and benefits/risks of treating mildhypercortisolemia
![Page 29: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/29.jpg)
QUALITY OF EVIDENCE High Quality Moderate Quality Low Quality Very Low Quality
Description of Evidence
• Well-performed RCTs
• Very strong evidence from unbiased observational studies
• RCTs with some limitations
• Strong evidence from unbiased observational studies
• RCTs with serious flaws
• Some evidence from observational studies
• Unsystematic clinical observations
• Very indirect evidence observational studies
STRENGTH OF RECOMMENDATION
Strong (1): “We recommend…”Benefits clearly outweigh harms and burdens, or vice versa
1|⊕⊕⊕⊕ 1|⊕⊕⊕O 1|⊕⊕OO 1|⊕OOO
Conditional (2):“We suggest…”Benefits closely balanced with harms and burdens
2|⊕⊕⊕⊕ 2|⊕⊕⊕O 2|⊕⊕OO 2|⊕OOO
GRADE Classification of Guideline Recommendations
![Page 30: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/30.jpg)
Obvious Disease Recurrence• Second line therapeutic options, including surgical and
medical options• In patients with CD who underwent a non-curative
surgery or for whom surgery was not possible, we suggest a shared decision-making approach, as there are several available second-line therapies (2|⊕⊕)
o repeat transsphenoidal surgeryo radiotherapyo medical therapyo bilateral adrenalectomy
![Page 31: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/31.jpg)
Medical TherapiesSteroidogenesis inhibitors
Metyrapone500 – 6 g/d; Q 6-8 h dosing
Quick onset of action Adverse effects: GI, hirsutism, HT, hypokalemia; accessibility variable across countries
Ketoconazole 400-1600 mg/d; Q 6-8 h dosing
Quick onset of action Adverse effects: GI, hepatic dyscrasia (death), male hypogonadism; requires acid for biologic activity; DDIs
MitotaneStarting dose 250 mg; 500 mg – 8 g/d
Adrenolytic; approved for adrenal cancer
Slow onset action; lipophilic/long half life, teratogenic; GI and CNS: GI, CNS, gynecomastia, low WBC and T4, ↑ LFTs; ↑ CBG, DDIs
EtomidateBolus and titrate
Intravenous, quick onset of action Requires monitoring in ICU
Pituitary-directed
Cabergoline Adverse effects: asthenia, GI, dizziness
Pasireotide Most successful when UFC <2-fold normal
Subcutaneous; Adverse effects: diarrhea, nausea, cholelithiasis, hyperglycemia, transient ↑ LFTs; ↑QTc interval
Glucocorticoid receptor-directed
Glucocorticoid receptor-directedMifepristone
Difficult to titrate (no biomarker); abortifacient; Adverse effects: fatigue, nausea, vomiting, arthralgias, headache, hypertension, hypokalemia, edema, endometrial thickening
![Page 32: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/32.jpg)
Special Cases: Pregnancy
How would choice of therapies be different if this individual were seeking pregnancy as she began?
Hypercortisolism suppresses the gonadal axis decreased fecundity
Some treatment approaches also decrease ovulation/spermatogenesis
Others may be abortifacient/teratogenic
Choose wisely
![Page 33: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/33.jpg)
Recommended Future Research Aims
Identify biologic markers and tissue factors to:• Quantify glucocorticoid exposure to guide clinical decision
making• Determine whether the patient is in remission• Monitor patient response to medical therapy
Ascertain the best follow up strategy to detect recurrence
![Page 34: Treatment of Cushing’s Syndrome...• Patient is placed on metformin with normalization of blood glucose. • 4 months later, she has gained an additional 10 lbs [5 kg]. She now](https://reader033.vdocuments.us/reader033/viewer/2022041823/5e5f8e17c56d2b59ea39babc/html5/thumbnails/34.jpg)
Evaluate benefits/risks of treating mild hypercortisolemia
Evaluate the utility of thromboembolic prophylaxis before and after remission
Assess long-term quality of life and cognitive changes and determine optimal treatment strategies
Recommended Future Research Aims